Physiomics Plc (AIM:PYC)

Market Cap	2.04M +58.3%
Revenue (ttm)	1.01M +85.8%
Net Income	-485.25K
EPS	-0.00
Shares Out	453.21M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	0.4450
Previous Close	0.4450
Day's Range	0.4352 - 0.4500
52-Week Range	0.2525 - 0.8000
Beta	1.04
Analysts	n/a
Price Target	n/a
Earnings Date	Sep 29, 2026

About Physiomics

Physiomics Plc provides consulting services to pharmaceutical companies in the areas of outsourced quantitative pharmacology and computational biology in the United Kingdom, the United States, and the European Union Switzerland. The company offers modeling, simulation, and data analysis services covering various ranges of oncology research and development using its proprietary Virtual Tumour predictive software. It also develops technology for use in the field of personalized medicine. Physiomics Plc was incorporated in 2001 and is based in Oxf...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2001
• Employees: 10
• Stock Exchange: London Stock Exchange AIM
• Ticker Symbol: PYC

Financial Performance

In fiscal year 2025, Physiomics's revenue was 834,156, an increase of 46.20% compared to the previous year's 570,561. Losses were -415,254, -31.85% less than in 2024.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Aug 14, 2026

Data Sources Report a data error